Our team

Management Team
Ana Seco
Co-Founder & CFO
ana.seco @ aptusbiotech.com

Graduate in Economy, MBA IESE Business School, Co-Founder of AptusBiotech and AptaTargets. Expert in Biotech Management. She is the Sole Administrator and Financial Manager of the company.

Dr. Víctor M. González
COO
victor.m.gonzalez @ aptusbiotech.com

Senior researcher at the Ramón y Cajal Institute for Health Research (IRYCIS), where he directs the Aptamer Research Group. PhD in Molecular Biology from the Autonomous University of Madrid.

Leer más

Miguel Moreno
CSO
miguel.moreno @ aptusbiotech.com

In January 2020 he joined Aptus Biotech as Chief Scientific Officer, where he is responsible of the coordination and monitoring of the different projects of the company, provide scientific support in all R&D&I 

Leer más

Technical Team
Dr. Gerónimo Fernández, Technical Director & QA
g.fernandez @ aptusbiotech.com

Graduated in Chemistry, specialty Biochemistry and Molecular Biology (UAM 1997) and PhD. in CC. Chemistry, Biomedicine program (UAH 2002), I have developed my professional career focused on therapy and human diagnosis

Leer más

Ana García-Sacristán
Project Manager and Head of Gender Policy
garciasaa @ aptusbiotech.com

Graduated in Chemistry at the Universidad Complutense de Madrid in 1998. She obtained the PH.D degree in 2004 at the Universidad Complutense of Madrid working with genes involved in cell differentiation

Leer más

Celia Pinto Researcher
celia.pinto @ aptusbiotech.com

Degree in Biology (2009), Master of Health Analysis at the Complutense University (2013).and PhD. in Biology at UAH (2019). More than 10 years of experience in aptamers. She has been focused on the development of the aptamer apMNKQ2

Leer más

Ana Salgado Researcher
ana.salgado @ aptusbiotech.com

Graduated in Biology (UAM) and MsC in genetics and cell biology (UAM, UAH, UCM), she is currently undertaking the PhD in Biology at the UAM.She has more than 5 years of experience in aptamers. She owns a CAM Doctor Industrial fellowship

Leer más

Scientific Advisor
Javier Cortés

Director of the Baselga Oncologic Institute (IOB), Clinical Researcher of the Breast Cancer Research Program of the Vall d’Hebrón Oncology Institute of Barcelona. Actively involved in the development of 4 candidates drugs against metastatic breast cancer in Europe from which approved: pertuzumab, eribulina y everolimus. National Prize of Medicine 2021

Elena Martín

Leader of the Aptamer Group at IRYCIS. PhD. in Biochemistry at UAM. Postdoctoral researcher at UAH. Expert in aptamers, signalling and molecular biology of cancer as well as ischemic pathologies.